Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in TNGX — Tango Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in TNGX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,806,442
+$1,494,429 QoQ
Shares Held
86,350
+145.2% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
16 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TNGX Over Time

Shares Held

Position Value (USD)

Derivatives in TNGX

reported options exposure · as of Mar 31, 2026
CallValue
$863,996
CallShares
41,300
PutValue
$698,728
PutShares
33,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. TNGX ranks #116 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TNGX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,806,442 86,350
2026-03-31 $863,996 41,300
2026-03-31 $698,728 33,400
2025-12-31 $312,013 35,216
2025-12-31 $370,348 41,800
2025-09-30 $120,120 14,300
2025-09-30 $519,120 61,800
2025-09-30 $746,247 88,839
2025-06-30 $1,241,328 242,447
2025-03-31 $91,262 66,615
2024-12-31 $78,093 25,273
2024-09-30 $125,571 16,308
2024-06-30 $127,241 14,830
2024-03-31 $340,561 42,892
2023-12-31 $261,518 26,416
2023-09-30 $279,675 24,838
2023-06-30 $51,951 15,648
2023-03-31 $110,971 28,094
2022-09-30 $48,797 13,480
2022-03-31 $2,516,560 332,000
2021-12-31 $1,278,667 116,880